Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Amiodarone may remain a key antiarrhythmic option; leaves open its comparative role versus newer agents in contemporary practice.
Editorials| October 31 2001 Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias? Subject Area: Cardiovascular System , Pharmacology Gordon Tomaselli Gordon Tomaselli Division of Cardiology, The Johns Hopkins University, Baltimore, Md., USA Search for other works by this author on: This Site PubMed Google Scholar Heart Drug (2001) 1 (4): 183–185. https://doi.org/10.1159/000048958 Article history Published Online: October 31 2001 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Gordon Tomaselli; Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias?. Heart Drug 1 August 2001; 1 (4): 183–185. https://doi.org/10.1159/000048958 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsHeart Drug Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. © 2001 S. Karger AG, Basel2001Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Gordon F. Tomaselli (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: